Know Cancer

or
forgot password

Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six


N/A
N/A
1 Year
Open (Enrolling)
Both
Hemangioma

Thank you

Trial Information

Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six


This study seeks to examine a potential relationship between CTCF genotype and hemangioma
size and growth rate. In addition to the initial visit, patients will return to our clinic
for evaluation at two weeks, one month, two months, six months, and one year. At each
visit, patients' hemangiomas will be measured and photographed. At one point over the
course of evaluation, a blood sample will be taken from each patient for evaluation of C/T
polymorphism at CTCF binding site six.


Inclusion Criteria:



- Hemangioma must appear within one month prior to enrollment

Exclusion Criteria:

- Hemangioma appeared before one month prior to enrollment

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Deepak Narayan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Yale University

Authority:

United States: Institutional Review Board

Study ID:

0507000430

NCT ID:

NCT00974129

Start Date:

September 2009

Completion Date:

May 2011

Related Keywords:

  • Hemangioma
  • Hemangioma
  • Hemangioma, Capillary

Name

Location

Yale Dermatology AssociatesNew HAven, Connecticut  06519